Index RUT
P/E -
EPS (ttm) -1.07
Insider Own 27.56%
Shs Outstand 32.52M
Perf Week 0.88%
Market Cap 196.59M
Forward P/E -
EPS next Y -0.96
Insider Trans -0.26%
Shs Float 24.96M
Perf Month -11.35%
Income -34.78M
PEG -
EPS next Q -0.33
Inst Own 58.74%
Short Float 5.36%
Perf Quarter -20.28%
Sales 50.73M
P/S 3.88
EPS this Y 1.42%
Inst Trans 3.50%
Short Ratio 7.23
Perf Half Y 1.42%
Book/sh 4.77
P/B 1.20
EPS next Y 13.64%
ROA -17.04%
Short Interest 1.34M
Perf Year -26.36%
Cash/sh 3.89
P/C 1.47
EPS next 5Y -
ROE -20.61%
52W Range 4.85 - 12.51
Perf YTD -49.20%
Dividend Est. -
P/FCF -
EPS past 5Y -31.19%
ROI -21.70%
52W High -54.44%
Beta 1.02
Dividend TTM -
Quick Ratio 7.53
Sales past 5Y 21.26%
Gross Margin 46.13%
52W Low 17.53%
ATR (14) 0.34
Dividend Ex-Date -
Current Ratio 8.37
EPS Y/Y TTM 7.26%
Oper. Margin -83.26%
RSI (14) 41.31
Volatility 3.62% 5.97%
Employees 230
Debt/Eq 0.03
Sales Y/Y TTM 5.62%
Profit Margin -68.56%
Recom 1.00
Target Price 15.33
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q 14.87%
Payout -
Rel Volume 2.88
Prev Close 5.76
Sales Surprise 7.52%
EPS Surprise 8.84%
Sales Q/Q 5.31%
Earnings Apr 30 BMO
Avg Volume 184.96K
Price 5.70
SMA20 0.30%
SMA50 -10.57%
SMA200 -16.97%
Trades
Volume 532,487
Change -1.04%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-07-23 Initiated
Stephens
Overweight
$14
Oct-15-21 Resumed
Cowen
Outperform
Jan-12-21 Initiated
William Blair
Outperform
Jan-12-21 Initiated
SVB Leerink
Outperform
$70
Jan-12-21 Initiated
Stifel
Buy
$65
Jan-12-21 Initiated
Cowen
Outperform
May-09-24 09:35AM
May-01-24 08:49AM
03:09AM
12:08AM
(Thomson Reuters StreetEvents)
Apr-30-24 11:53AM
09:35AM
Loading…
09:35AM
08:55AM
07:45AM
07:30AM
Apr-23-24 07:00AM
Mar-12-24 07:00AM
Mar-07-24 12:02PM
Mar-05-24 07:33AM
07:00AM
Feb-29-24 07:00AM
07:00AM
Loading…
Feb-22-24 07:00AM
Feb-20-24 07:00AM
Feb-02-24 11:01PM
Dec-28-23 12:00PM
Dec-27-23 10:30AM
Dec-22-23 01:01PM
Dec-19-23 09:55AM
Dec-18-23 05:34AM
Nov-14-23 07:00AM
Nov-09-23 03:37PM
Nov-07-23 08:14AM
07:00AM
Nov-06-23 04:30PM
Oct-31-23 07:00AM
Oct-24-23 04:30PM
07:00AM
Loading…
07:00AM
Sep-26-23 07:00AM
Sep-18-23 07:00AM
Sep-15-23 07:00AM
Aug-26-23 07:50AM
Aug-08-23 09:15AM
07:00AM
Aug-07-23 07:00AM
Jul-31-23 07:00AM
Jul-25-23 07:00AM
Jul-16-23 08:42AM
Jul-13-23 05:42AM
May-30-23 07:00AM
May-23-23 09:54AM
07:00AM
May-09-23 08:25AM
07:00AM
May-04-23 07:00AM
Apr-26-23 07:00AM
Apr-25-23 07:00AM
Apr-18-23 11:14AM
Mar-08-23 02:22AM
(Thomson Reuters StreetEvents)
Mar-07-23 08:25AM
07:00AM
Feb-27-23 06:05PM
Feb-21-23 07:00AM
Feb-14-23 07:00AM
Feb-07-23 01:37PM
Feb-06-23 05:16AM
Jan-17-23 07:00AM
Dec-29-22 06:02AM
Dec-07-22 07:00AM
Nov-16-22 06:24AM
Nov-14-22 11:44AM
10:05AM
07:00AM
Nov-10-22 07:00AM
Nov-09-22 07:00AM
Nov-02-22 07:00AM
Oct-19-22 07:00AM
Oct-12-22 05:00PM
Sep-29-22 07:50AM
Aug-09-22 04:00PM
08:45AM
07:30AM
07:00AM
Jul-27-22 07:00AM
Jul-25-22 07:21AM
Jul-19-22 07:00AM
Jun-13-22 04:22PM
Jun-02-22 07:00AM
May-26-22 07:00AM
May-11-22 02:30AM
May-10-22 08:15AM
07:00AM
May-09-22 07:00AM
May-03-22 07:00AM
Apr-21-22 07:00AM
Apr-12-22 05:37PM
07:00AM
Mar-08-22 05:58PM
Mar-07-22 10:30PM
05:15PM
04:05PM
Mar-02-22 04:30PM
Feb-15-22 07:00AM
Feb-14-22 12:24PM
Feb-08-22 07:00AM
Jan-21-22 11:37AM
Jan-09-22 07:00PM
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Knopp Kevin J. President and CEO May 10 '24 Buy 5.77 10,000 57,700 498,981 May 10 06:36 PM Knopp Kevin J. President and CEO May 09 '24 Buy 5.83 10,000 58,300 488,981 May 09 04:34 PM Knopp Kevin J. President and CEO May 08 '24 Buy 5.72 10,000 57,200 478,981 May 08 09:31 PM Knopp Kevin J. President and CEO May 07 '24 Buy 5.60 10,000 56,000 468,981 May 07 06:07 PM Knopp Kevin J. President and CEO Apr 16 '24 Option Exercise 1.75 47,000 82,250 458,981 Apr 16 04:11 PM Brown Christopher D. Chief Product Officer Apr 01 '24 Option Exercise 1.75 3,600 6,300 884,994 Apr 02 04:06 PM Griffith Joseph H. IV Chief Financial Officer Mar 26 '24 Option Exercise 1.58 8,437 13,330 93,437 Mar 27 04:16 PM Griffith Joseph H. IV Chief Financial Officer Feb 02 '24 Sale 7.09 9,711 68,873 80,000 Feb 02 07:10 PM Knopp Kevin J. President and CEO Feb 01 '24 Sale 7.00 9,071 63,461 411,981 Feb 02 04:39 PM Griffith Joseph H. IV Chief Financial Officer Feb 01 '24 Sale 7.00 5,698 39,892 89,711 Feb 02 07:10 PM Turner Michael S. Chief Legal & Admin Officer Feb 01 '24 Sale 6.99 5,232 36,559 9,105 Feb 02 04:40 PM Brown Christopher D. Chief Product Officer Feb 01 '24 Sale 7.01 3,957 27,730 886,394 Feb 02 04:37 PM Griffith Joseph H. IV Chief Financial Officer Dec 28 '23 Sale 12.08 6,000 72,480 80,000 Jan 02 05:01 PM Brown Christopher D. Chief Product Officer Dec 21 '23 Sale 9.12 7,370 67,214 877,905 Dec 21 04:46 PM Brown Christopher D. Chief Product Officer Dec 20 '23 Sale 9.10 5,235 47,638 885,275 Dec 21 04:46 PM Brown Christopher D. Chief Product Officer Dec 19 '23 Sale 9.08 7,395 67,147 890,510 Dec 21 04:46 PM Griffith Joseph H. IV Chief Financial Officer Dec 19 '23 Sale 9.08 5,580 50,666 86,000 Dec 21 04:47 PM Brown Christopher D. Chief Product Officer Jun 07 '23 Sale 10.03 4,470 44,834 897,905 Jun 09 04:17 PM Knopp Kevin J. President and CEO Jun 05 '23 Option Exercise 1.75 28,500 49,875 396,348 Jun 05 04:07 PM Knopp Kevin J. President and CEO May 23 '23 Sale 10.12 60,000 607,200 367,848 May 25 04:08 PM Brown Christopher D. Chief Technology Officer May 23 '23 Sale 10.02 10,000 100,200 892,375 May 25 04:12 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite